Janux Therapeutics, Inc. (JANX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.58
Day's range
$14.29

Janux Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 11.19 M $155.54 M   0.00% 17.86%
BLACKROCK, INC. 05/13/2026 5.43 M $75.52 M   33.16% 8.67%
JANUS HENDERSON GROUP PLC 05/18/2026 4.20 M $58.28 M   -21.57% 6.70%
PROSIGHT MANAGEMENT, LP 05/15/2026 3.55 M $49.35 M   48.38% 5.67%
FMR LLC 05/15/2026 2.54 M $35.25 M   -27.81% 4.05%
STATE STREET CORP 05/15/2026 2.46 M $34.25 M   -36.07% 3.93%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 1.81 M $25.18 M   100.00% 2.89%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 1.79 M $24.88 M   0.00% 2.86%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 1.60 M $22.26 M   23.06% 2.56%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.60 M $22.21 M   -0.78% 2.55%
05/08/2026 1.29 M $17.93 M   100.00% 2.06%
DEEP TRACK CAPITAL, LP 05/15/2026 1.19 M $16.50 M   1,225.26% 1.89%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.16 M $16.07 M   20.20% 1.84%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.15 M $15.94 M   2.98% 1.83%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 1.09 M $15.15 M   23.10% 1.74%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 1.00 M $13.90 M   0.00% 1.60%
ORBIMED ADVISORS LLC 05/15/2026 983.60 K $13.67 M   -49.67% 1.57%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 809.91 K $11.26 M   100.00% 1.29%
BANK OF AMERICA CORP /DE/ 05/18/2026 801.65 K $11.14 M   8.58% 1.28%
IRENIC CAPITAL MANAGEMENT LP 05/18/2026 765.80 K $10.64 M   100.00% 1.22%
WOODLINE PARTNERS LP 05/15/2026 738.03 K $10.26 M   -28.15% 1.18%
MORGAN STANLEY 05/15/2026 703.94 K $9.78 M   13.84% 1.12%
SQUAREPOINT OPS LLC 05/15/2026 604.00 K $8.40 M   54.49% 0.96%
GOLDMAN SACHS GROUP INC 05/15/2026 602.01 K $8.37 M   -43.93% 0.96%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 500.00 K $6.95 M   100.00% 0.80%
ALGERT GLOBAL LLC 05/14/2026 443.40 K $6.16 M   141.81% 0.71%
MILLENNIUM MANAGEMENT LLC 05/15/2026 386.81 K $5.38 M   33.47% 0.62%
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. 05/12/2026 376.50 K $5.23 M   0.00% 0.60%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 367.01 K $5.10 M   2.29% 0.59%
HRT FINANCIAL LP 05/14/2026 366.70 K $5.10 M   477.08% 0.59%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 362.50 K $5.04 M   20.63% 0.58%
NORTHERN TRUST CORP 05/14/2026 362.18 K $5.03 M   6.40% 0.58%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 354.33 K $4.93 M   -9.26% 0.57%
CITADEL ADVISORS LLC 05/15/2026 352.18 K $4.90 M   -68.10% 0.56%
MAN GROUP PLC 05/15/2026 342.99 K $4.77 M   431.66% 0.55%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 313.65 K $4.36 M   100.00% 0.50%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 298.55 K $4.15 M   21.63% 0.48%
JANE STREET GROUP, LLC 05/12/2026 251.74 K $3.50 M   -53.40% 0.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 245.80 K $3.42 M   15.67% 0.39%
JPMORGAN CHASE & CO 05/13/2026 229.27 K $2.99 M   34.46% 0.37%
JUMP FINANCIAL, LLC 05/14/2026 221.80 K $3.08 M   129.41% 0.35%
UBS GROUP AG 05/05/2026 219.81 K $3.06 M   -62.75% 0.35%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 197.15 K $2.74 M   -8.73% 0.31%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/14/2026 195.16 K $2.54 M   -26.92% 0.31%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 05/05/2026 168.98 K $2.45 M   100.00% 0.27%
BML CAPITAL MANAGEMENT, LLC 05/06/2026 154.96 K $2.15 M   100.00% 0.25%
Y-INTERCEPT (HONG KONG) LTD 04/27/2026 139.97 K $1.95 M   100.00% 0.22%
WALLEYE CAPITAL LLC 05/13/2026 130.62 K $1.82 M   -59.56% 0.21%
RANGELEY CAPITAL, LLC 05/15/2026 122.50 K $1.70 M   382.02% 0.20%
BANK OF NEW YORK MELLON CORP 05/05/2026 119.83 K $1.67 M   -1.84% 0.19%

Janux Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 241 institutional investors and hedge funds held shares of Janux Therapeutics Inc. The most heavily invested institutionals were:

PANAGORA ASSET MANAGEMENT INC: 269,113

Y-Intercept (Hong Kong) Ltd: 196,487

Bank of New York Mellon Corp: 135,072

Russell Investments Group, Ltd.: 81,601

CITIGROUP INC: 70,235

CONGRESS ASSET MANAGEMENT CO /MA: 67,610

95.09% of Janux Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 63.45 M shares in the last 24 months. This purchase volume represents approximately $887.04 M in transactions.